10597-54-3

Usage

Chemical Structure

1H-Benzimidazol-5-amine,7-chloro

Explanation

This describes the specific arrangement of atoms and functional groups in the molecule. The compound is a derivative of benzimidazole, with an amino group (-NH2) at the 5-position and a chlorine atom (-Cl) at the 7-position.

Explanation

The compound is derived from the benzimidazole structure, which is a fused-ring system consisting of a benzene ring and an imidazole ring.

Explanation

The amino group (-NH2) is attached to the 5th position of the benzimidazole ring.

Explanation

The chlorine atom (-Cl) is attached to the 7th position of the benzimidazole ring.

Explanation

Due to its unique chemical structure, 1H-Benzimidazol-5-amine,7-chloro-(9CI) may have potential uses in various fields, including the development of new drugs and materials.

Explanation

As with any chemical compound, it is important to handle 1H-Benzimidazol-5-amine,7-chloro-(9CI) with care, as it may possess hazardous properties that could pose risks to human health or the environment.

Explanation

1H-Benzimidazol-5-amine,7-chloro-(9CI) should be used in a controlled laboratory environment to ensure safety and proper handling.

Explanation

To fully understand the properties and potential uses of 1H-Benzimidazol-5-amine,7-chloro-(9CI), additional research and testing are necessary. This will help determine its safety, efficacy, and potential applications in various fields.

Derivative of Benzimidazole

Yes

Amino Group Position

5

Chlorine Atom Position

7

Potential Applications

Pharmaceutical and chemical research, drug development, and material development

Hazardous Properties

May have hazardous properties

Laboratory Environment

Controlled

Further Research and Testing

Likely needed

Upstream product

• 15476-97-8 4-chloro-6-nitro-1⁽³⁾H-benzimidazole 
• 64-18-6 formic acid 
• 17625-81-9 6-chloro-2,4-diaminobenzimidazole 

Relevant academic research and scientific papers

5-SULFAMOYL-2-HYDROXYBENZAMIDE DERIVATIVES

The invention is directed to substituted salicylamide derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof. The compounds of the invention are inhibitors of CD73 and can be useful in the treatment of cancer, pre-cancerous syndromes and diseases associated with CD73 inhibition, such as AIDS, the treatment of HIV, autoimmune diseases, infections, atherosclerosis, and ischemia–reperfusion injury. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CD73 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

SUBSTITUTED PYRIDINYL-PYRIMIDINES AND THEIR USE AS MEDICAMENTS

The invention relates to new substituted pyridinyl-pyrimidines of formula 1 wherein ring A is a five-membered saturated or unsaturated carbocyclic ring which optionally comprises one, two or three heteroatoms each independently from each other selected from the group N, S and O, wherein R1, R2, R4, R3, R5 and R6 are defined as in claim 1 and wherein ring A is further optionally substituted by one or two further substituents and the pharmaceutically acceptable salts, diastereomers, enantiomers, racemates, hydrates and solvates of the aforementioned compounds.

SUBSTITUTED PYRIDINYL-PYRIMIDINES AND THEIR USE AS MEDICAMENTS

The invention relates to new substituted pyridinyl-pyrimidines of formula 1 wherein ring A is a five-membered saturated or unsaturated carbocyclic ring which optionally comprises one, two or three heteroatoms each independently from each other selected from the group N, S and O, wherein R1, R2, R4, R3, R5 and R6 are defined as in claim 1 and wherein ring A is further optionally substituted by one or two further substituents and the pharmaceutically acceptable salts, diastereomers, enantiomers, racemates, hydrates and solvates of the aforementioned compounds.